Chipping away at gallstones

Nature Medicine

Volumn 10, Issue 12, 2004, Pages 1301-1302

  Goralski, Kerry B ^a,b   Sinal, Christopher J ^a  

^a Department of Pharmacology ^*  (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID; CHENODEOXYCHOLIC ACID; ENZYME INHIBITOR; FARNESOID X RECEPTOR AGONIST; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

BILE ACID METABOLISM; CHOLESTEROL STONE; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GALLSTONE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TRANSPORT KINETICS; TREATMENT OUTCOME;

ANIMALS; BILE; CHOLESTEROL; DNA-BINDING PROTEINS; GALLSTONES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; MICE; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 11144335495     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1204-1301     Document Type: Short Survey

References (12)

1. Moschetta, A., Bookout, A.L. & Mangelsdorf, D.J. Nat. Med. 10, 1352-1358 (2004).
2. Heuman, D., Wassef, W. & Vlahcevic, Z. Gallstones, in Shiff's Diseases of the Liver (eds. Shift, E.R., Sorrell, M.F. & Maddrey, W.C.) 631-645 (Lippincott-Raven, Philadelphia, 1999).
3. Sinai, C.J. et al. Cell 102, 731-744 (2000).
4. Makishima, M. et al. Science 284, 1362-1355 (1999).
5. Parks, D.J. et al. Science 284, 1365-1368 (1999).
6. Wittenburg, H. et al. Gastroenterology 125, 868-881 (2003).
7. Maloney, P.R. et al. J. Med. Chem. 43, 2971-2974 (2000).
8. Chen, F. et al. Gastroenterology 126, 756-764 (2004).
9. Konikoff, F.M. MedGenMed 5, 8 (2003).
10. Gerloff, T. et al. J. Biol. Chem. 273, 10046-10050 (1998).
11. Yu, L. et al. Proc. Natl. Acad. Sci. USA 99, 16237-16242 (2002).
12. Smit, J.J. et al. Cell 75, 451-462 (1993).